Compare · head to head
Champions Oncology vs Tempus AI
Champions Oncology ranks higher overall — 360 rank 32 vs 28.
Champions Oncology leads on Value (59 vs 42) and Quality (52 vs 35). Tempus AI leads on Growth (58 vs 31) and Sentiment (60 vs 54). The two are close on Safety.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Life Sciences Tools & Services | Life Sciences Tools & Services |
| Size | Small | Medium |
| ISIN | US15870P3073 | US88023B1035 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 32 | 28 |
| Value | 59 | 42 |
| Quality | 52 | 35 |
| Growth | 31 | 58 |
| Safety | 34 | 31 |
| Sentiment | 54 | 60 |
| Quality details | ||
| Profitability | 39 | 23 |
| Cash Truth | 65 | 47 |
Champions Oncology vs Charles River LaboratoriesChampions Oncology vs InotivChampions Oncology vs PersonalisChampions Oncology vs Cytek BiosciencesAdd a third stock →
Full analyses: Champions Oncology · Tempus AI
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100